Search Results - "Burton, Cathy"

Integrating Evidence-Based Practices in Middle Science Reading

Authors: Kroeger, Stephen D. Burton, Cathy Preston, Christopher

Source: TEACHING Exceptional Children. Jan-Feb 2009 41(3):6-15.

Peer Reviewed: Y

Page Count: 10

Descriptors: Middle School Students, Learning Strategies, Peer Teaching, Scientific Concepts, Educational Practices, Theory Practice Relationship, Cloze Procedure, Questionnaires, Teacher Attitudes, Student Attitudes, Intervention, Instructional Effectiveness, Reading Difficulties

Access URL: https://www.cec.sped.org/Content/NavigationMenu/Publications2/TEACHINGExceptionalChildren/default.htm

Student Voice and Critical Reflection: Helping Students at Risk.

Authors: Kroeger, Steve Burton, Cathy Comarata, Andrea

Source: TEACHING Exceptional Children. Jan-Feb 2004 36(3):50-57.

Peer Reviewed: Y

Page Count: 8

Descriptors: Data Collection, High Risk Students, Intervention, Interviews, Middle Schools, Photography, Reflective Teaching, Self Evaluation (Individuals), Student Evaluation, Teacher Student Relationship, Team Teaching, Teamwork

Journal Code: CIJJUl2004

Access URL: https://www.cec.sped.org/Content/NavigationMenu/Publications2/TEACHINGExceptionalChildren/default.htm

Increasing Evidence for the Association of Breast Implant-Associated Anaplastic Large Cell Lymphoma and Li Fraumeni Syndrome.

Authors: Adlard, Julian Burton, Cathy Turton, Philip

Source: Case Reports in Genetics. 7/16/2019, p1-5. 5p.

Discovery of Pre-Treatment FDG PET/CT-Derived Radiomics-Based Models for Predicting Outcome in Diffuse Large B-Cell Lymphoma.

Authors: Frood, Russell Clark, Matthew Burton, Cathy et al.

Source: Cancers. Apr2022, Vol. 14 Issue 7, p1711. 13p.

Utility of pre-treatment FDG PET/CT-derived machine learning models for outcome prediction in classical Hodgkin lymphoma.

Authors: Frood, Russell Clark, Matt Burton, Cathy et al.

Source: European Radiology. Oct2022, Vol. 32 Issue 10, p7237-7247. 11p. 1 Color Photograph, 5 Charts, 4 Graphs.

COVID‐19‐related mortality in a real‐world cohort of 18 883 patients with premalignant and malignant haematological neoplasms: An analysis from the UK's Haematological Malignancy Research Network.

Authors: Smith, Alexandra Frobisher, Clare Varghese, Abraham et al.

Source: British Journal of Haematology. Feb2026, Vol. 208 Issue 2, p486-497. 12p.

Management of relapsed or refractory large B‐cell lymphoma: A British Society for Haematology Guideline.

Authors: Chaganti, Sridhar Fox, Christopher P. Maybury, Bernard D. et al.

Source: British Journal of Haematology. Jun2025, Vol. 206 Issue 6, p1593-1603. 11p.

Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical Hodgkin lymphoma: A British Society for Haematology Good Practice Paper.

Authors: Barrett, Aisling Shah, Nimish Chadwick, Andrew et al.

Source: British Journal of Haematology. Jan2025, Vol. 206 Issue 1, p74-85. 12p.

The management of newly diagnosed large B‐cell lymphoma: A British Society for Haematology Guideline.

Authors: Fox, Christopher P. Chaganti, Sridhar McIlroy, Graham et al.

Source: British Journal of Haematology. Apr2024, Vol. 204 Issue 4, p1178-1192. 15p.

Prognostic indices in diffuse large B‐cell lymphoma in the rituximab era: an analysis of the UK National Cancer Research Institute R‐CHOP 14 versus 21 phase 3 trial.

Authors: Gleeson, Mary Counsell, Nicholas Cunningham, David et al.

Source: British Journal of Haematology. Mar2021, Vol. 192 Issue 6, p1015-1019. 5p.

UK Guidelines on the Diagnosis and Treatment of Breast Implant‐Associated Anaplastic Large Cell Lymphoma on behalf of the Medicines and Healthcare products Regulatory Agency Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group.

Authors: Turton, Philip El‐Sharkawi, Dima Lyburn, Iain et al.

Source: British Journal of Haematology. Feb2021, Vol. 192 Issue 3, p444-458. 15p.

Application of the LymphGen classification tool to 928 clinically and genetically‐characterised cases of diffuse large B cell lymphoma (DLBCL).

Authors: Runge, Hendrik F. P. Lacy, Stuart Barrans, Sharon et al.

Source: British Journal of Haematology. Jan2021, Vol. 192 Issue 1, p216-220. 5p.

The investigation and management of follicular lymphoma.

Authors: McNamara, Christopher Montoto, Silvia Eyre, Toby A. et al.

Source: British Journal of Haematology. Nov2020, Vol. 191 Issue 3, p363-381. 19p.

Frontline management of nodular lymphocyte predominant Hodgkin lymphoma – a retrospective UK multicentre study.

Authors: Wilson, Matthew R. Bagguley, Timothy Smith, Alexandra et al.

Source: British Journal of Haematology. Sep2019, Vol. 186 Issue 6, pe214-e217. 4p. 1 Chart, 1 Graph.

Cell‐of‐origin in diffuse large B‐cell lymphoma: findings from the UK's population‐based Haematological Malignancy Research Network.

Authors: Painter, Daniel Barrans, Sharon Lacy, Stuart et al.

Source: British Journal of Haematology. May2019, Vol. 185 Issue 4, p781-784. 4p. 1 Chart, 1 Graph.

Promoting breast cancer awareness in older women during the seasonal flu vaccination campaign.

Authors: Kaushal, Aradhna McCormick, Katrina Warburton, Fiona et al.

Source: British Journal of Nursing. 1/1/2019, Vol. 28 Issue 1, p43-49. 7p.

A Generic Model for Follicular Lymphoma: Predicting Cost, Life Expectancy, and Quality-Adjusted-Life-Year Using UK Population-Based Observational Data.

Authors: Wang, Han-I Roman, Eve Crouch, Simon et al.

Source: Value in Health. Oct2018, Vol. 21 Issue 10, p1176-1185. 10p.

Cohort Profile: The Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort.

Authors: Smith, Alexandra Howell, Debra Crouch, Simon et al.

Source: International Journal of Epidemiology. Jun2018, Vol. 47 Issue 3, p700-700. 8p.

Impact of novel therapies for mantle cell lymphoma in the real world setting: a report from the UK's Haematological Malignancy Research Network (HMRN).

Authors: Smith, Alexandra Roman, Eve Appleton, Simon et al.

Source: British Journal of Haematology. Apr2018, Vol. 181 Issue 2, p215-228. 14p. 5 Charts, 8 Graphs, 1 Map.

Results of a multicentre UK-wide retrospective study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the transplant naive setting.

Authors: Eyre, Toby A. Phillips, Elizabeth H. Linton, Kim M. et al.

Source: British Journal of Haematology. Nov2017, Vol. 179 Issue 3, p471-479. 9p.